Overview

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
0
Participant gender:
All
Summary
A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
GlaxoSmithKline
Criteria
Inclusion Criteria:

- Diagnosis of Major Depressive Disorder (MDD)

- Duration of current depressive episode 12 weeks - 24 months

- Patients can read and write at a level sufficient to provide a signed consent

- If female, patients must be practicing an acceptable method of birth control

Exclusion Criteria:

- Patients have other psychiatric disorders that would affect patient's response to
treatment

- Patients have not responded to two or more adequate courses of antidepressant therapy

- Patients cannot be currently abusing illicit drugs or alcohol

- Patients are not currently receiving psychotherapy

- Patients have received electroconvulsive therapy within 6 months prior to screening

- Patients are pregnant or lactating